Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease
Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;
10.1016/j.aohep.2024.101589
Association of sleep patterns and disorders with metabolic dysfunction-associated steatotic liver disease and liver fibrosis in contemporary American adults
Guannan Zong; Wangjia Mao; Ming Wen; Xiaoyun Cheng; Guanghui Liu;
10.1016/j.aohep.2024.101583
Knowledge about metabolic dysfunction-associated steatotic liver disease among the medical professionals from countries in the MENA region
Saleh A. Alqahtani; Yusuf Yilmaz; Mohamed El-Kassas; Khalid Alswat; Mohamed Mawardi; Faisal M. Sanai; Faisal Abaakhail; Saad Alghamdi; Waleed K. Al-Hamoudi; Fatema Nader; Maria Stepanova; Zobair M. Younossi;
10.1016/j.aohep.2024.101569